San Mateo, CA · Founded 2020 · Privately Held (backing)
Developer of medical test products designed to transform the detection and treatment of cancer and other complex diseases. PrognomIQ is based in San Mateo, CA and was founded in 2020. It is valued at about $316 million as of Oct 2026, set by institutional fund marks. It has raised $172 million across 3 recorded rounds; the latest was an $11.9 million early-stage round in Jan 2026.
PMV mark · valuation
$315.6M
Oct 2026
Priced at
—
Total raised
$171.8M
Last round
Early Stage VC
Jan 2026
Team — not yet on record
No current team members for PrognomIQ are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of PrognomIQ with a free account
·The complete investor list: 12 names
·Watch PrognomIQ: the Monday email on marks, rounds and moves
